Autonomize AI
Your trusted partner in solving critical business problems with Applied Artificial Intelligence (AI).
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | $28.0m | Series A | |
| Total Funding | 000k | ||
| USD | 2023 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Autonomize AI is a company that has developed a generative AI platform specifically for the healthcare and life sciences sectors. The platform is designed to process and analyze large volumes of unstructured data from various sources, such as clinical trials, research papers, and electronic health records. Its core technology utilizes what the company refers to as "Compound AI Agents" and "AI Copilots" to automate the organization, contextualization, and summarization of this data.
The primary clients for Autonomize AI are pharmaceutical companies, biotechnology firms, and research institutions that are engaged in drug discovery and clinical development. The company's business model is based on providing its platform as a service (SaaS), enabling these organizations to accelerate their research and development processes. By leveraging AI to extract insights from complex data sets, the platform helps its clients to make more informed decisions, potentially reducing the time and cost associated with bringing new therapies to market.
Keywords: AI platform, healthcare data, life sciences, drug discovery, clinical development, unstructured data, SaaS, data analysis, biomedical data, AI copilots